A U.S. Food and Drug Administration (FDA) expert panel will weigh authorization of Pfizer’s COVID-19 vaccine for children aged five to 11 on Tuesday as it prepares to vote on a recommendation. If the Centers for Disease Control and Prevention (CDC) ultimately endorses the shot, the vaccines could start being administered as soon as next week.
CDC
U.S. FDA panel weighs authorization of Pfizer’s COVID-19 vaccine for kids
More Videos
-
‘Mpox is not the new COVID,’ WHO says amid virus surge in Europe, Africa
-
Canada will attempt to get exemption from U.S. border rules for dogs: Holland
-
New rules for crossing U.S. border with dogs
-
Health Matters: CDC asks states to prepare rapid testing for bird flu as a precaution
-
‘Alarming increase’ of syphilis cases in Canada: top doctor
-
‘Life-threatening disease’: Locally transmitted malaria cases reported in U.S.
You are viewing an Accelerated Mobile Webpage.
View Original Article